Product identification
Medicine name:
Epirepress 15 mg, comprimidos para cães
Luminaletten vet, 15 mg tablets for dogs
Active substance:
- Phenobarbital
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Phenobarbital15.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN03AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Package description:
- (ID6) 200 Tablet: unspecified outer container with 2 Container (High Density PolyEthylene) each with 100 Tablet
- (ID5) 100 Tablet: unspecified outer container with 1 Container (High Density PolyEthylene) with 100 Tablet
- (ID4) 50 Tablet: unspecified outer container with 1 Container (High Density PolyEthylene) with 50 Tablet
- (ID3) 200 Tablet: unspecified outer container with 2 Bottle (Glass) each with 100 Tablet
- (ID2) 100 Tablet: unspecified outer container with 1 Bottle (Glass) with 100 Tablet
- (ID1) 50 Tablet: unspecified outer container with 1 Bottle (Glass) with 50 Tablet
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Manufacturing sites for batch release:
- Desitin Arzneimittel GmbH
Authorisation number:
- 711/01/13RFVPT
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0141/001
Concerned member states:
-
Austria
-
Belgium
-
Denmark
-
Netherlands
-
Portugal
-
Spain
-
Sweden
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 14/02/2022